SBRT: Clinical Trials

2 trials for SBRT, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 2
Phase 11Terminated 1

Follow SBRT: new trials by email Literature Review of SBRT trials Research Report on SBRT

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer
Drug GC4711, Placebo - SBRT, Borderline Resectable Pancreatic Cancer
Phase 2TerminatedGalera Therapeutics, Inc.1772021-05-072024-05-21
Phase I/II Study of SBRT and GC4711 for Centrally Located or Large NSCLC
GC4711 +SBRT, Placebo +SBRT - SBRT, NSCLC
Phase 1 / Phase 2TerminatedGalera Therapeutics, Inc.472020-10-182024-04-30

Sponsors

Galera Therapeutics, Inc. (2)

Countries

United States (2)  ·  Canada (1)  ·  France (1)  ·  United Kingdom (1)

Top investigators

Eugene P Kennedy, MD (1)

Results publications

PMID 34145168, PMID 38039992, PMID 38264869